IL6 and acute kidney injury: Mouse models with induced AKI demonstrate that IL-27 treatment can minimize kidney damage, expressed by less tubular injury, increased production of anti-inflammatory cytokines, and decreased production of TNF-alpha, IL-6, and IL-17A [81].